Robert Young Kim

Insider Reports History

Location
Emeryville, CA
Signature
/s/ Scott Bizily as Attorney-in-Fact for Robert Young Kim
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Young Kim:

Company Role Class Num Shares Value Price $ Report Date Ownership
4D Molecular Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 92,300 06 Mar 2025 Direct

Insider Reports Filed by Robert Young Kim

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FDMT 4D Molecular Therapeutics, Inc. 06 Mar 2025 1 $0 4 Chief Medical Officer 10 Mar 2025, 19:58
FDMT 4D Molecular Therapeutics, Inc. 07 Feb 2024 0 $0 3/A Chief Medical Officer 07 Feb 2024, 19:42
FDMT 4D Molecular Therapeutics, Inc. 05 Feb 2024 10 -$370,948 4 Chief Medical Officer 07 Feb 2024, 20:32
FDMT 4D Molecular Therapeutics, Inc. 11 Dec 2023 1 $0 4 Chief Medical Officer 13 Dec 2023, 16:05
FDMT 4D Molecular Therapeutics, Inc. 24 Mar 2023 0 $0 3 Chief Medical Officer 05 Apr 2023, 21:28